Review decisions
Showing 530 results of 1549 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01042
Product Type: Drug
Control Number: 254548
DIN(s): 02532468
Manufacturer: Vifor Fresenius Medical Care Renal Pharma Ltd.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2021-09-10
Decision / Authorization Date: 2022-08-16
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00984
Product Type: Drug
Control Number: 257327
Manufacturer: BGP Pharma ULC
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-10-06
Decision / Authorization Date: 2022-08-12
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00985
Product Type: Drug
Control Number: 255983
DIN(s): 02529653, 02529661
Manufacturer: Novartis Pharmaceuticals Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-08-23
Decision / Authorization Date: 2022-08-10
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01043
Product Type: Drug
Control Number: 255153
DIN(s): 02529688
Manufacturer: Tillotts Pharma AG
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-07-27
Decision / Authorization Date: 2022-08-08
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00980
Product Type: Drug
Control Number: 251360
DIN(s): 02529602
Manufacturer: Baxter Corporation
Submission Type: New Drug Submission
Date Filed / Submission Date: 2021-04-13
Decision / Authorization Date: 2022-08-03
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00978
Product Type: Drug
Control Number: 255908
Manufacturer: Janssen Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-08-18
Decision / Authorization Date: 2022-07-29
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00977
Product Type: Drug
Control Number: 256188
DIN(s): 02529548, 02529556
Manufacturer: AstraZeneca Canada Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2021-08-28
Decision / Authorization Date: 2022-07-28
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00989
Product Type: Drug
Control Number: 259417
Manufacturer: AstraZeneca Canada Inc.
Submission Type: Supplement to a New Drug Submission - Notice of Compliance with Conditions
Date Filed / Submission Date: 2021-12-09
Decision / Authorization Date: 2022-07-27
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01077
Product Type: Drug
Control Number: 257103
Manufacturer: Bristol-Myers Squibb Canada Co.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-09-29
Decision / Authorization Date: 2022-07-25
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00976
Product Type: Drug
Control Number: 255926
Manufacturer: Bristol-Myers Squibb Canada Co.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-08-20
Decision / Authorization Date: 2022-07-21